A theoretical framework for the immunoepidemiology of Plasmodium falciparum malaria

Parasite Immunology

Volumn 16, Issue 7, 1994, Pages 361-370

  GUPTA, SUNETRA ^a   P DAY, KAREN ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

disease; epidemiology; immunity; Keywords malaria; mathematical models

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; HUMAN; IMMUNITY; MALARIA FALCIPARUM; MATHEMATICAL MODEL; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AFRICA; AGE FACTORS; CHILD; CHILD, PRESCHOOL; HUMAN; IMMUNITY; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; PAPUA NEW GUINEA; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SUPPORT, NON-U.S. GOV'T;

EID: 0027977965     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.1994.tb00361.x     Document Type: Article

References (35)

1. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine
2. On strains or races of the malaria
3. The epidemiology of malaria in a population surrounding Madang, Papua New Guinea
4. Dynamics of malaria parasitaemia associated with febrile illness in children from a rural area of Madang, Papua New Guinea
5. Naturally acquired immunity to Plasmodium falciparum
6. Population genetics and dynamics of Plasmodium falciparum: an ecological view
7. Field studies of some of the basic factors concerned in the transmission of malaria
8. Small area variation in prevalence of an S‐antigen serotype of Plasmodium falciparum in villages of Madang, Papua New Guinea
9. The control of rural malaria by pyrethrin dusting
10. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa
11. Malaria parasite survey of some area in Southern Cameroons under United Kingdon Administration
12. Parasite virulence and disease patterns in P. falciparum malaria
13. Theoretical studies of the effects of genetic heterogeneity in the parasite population on the transmission dynamics of malaria
14. Antigenic diversity and the transmission dynamics of Plasmodium falciparum
15. Molecular analysis of the association of HLA‐B53 and resistance to severe malaria
16. Naturally acquired antibodies to sporozoites do not prevent malaria; vaccine development implications
17. A longitudinal study of seroreactivities to Plasmodium falciparum antigens in infants and children living in a holoendemic area of Liberia
18. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabuadi and P. yoelii yoelii
19. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium
20. Antibodies to the circumsporozoite protein and protective immunity to malaria sporozoites
21. Genetic diversity in Plasmodium falciparum
22. Cytokine and anti‐disease immunity to malaria
23. Malaria—a neglected disease
24. Antigens induces on erythrocytes by P. falciparum: expression of diverse and conserved determinants
25. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relationship to protection against infection
26. Factors determining the true reservoir of infection of Plasmodium falciparum and Wuchereria bancrofti in a West African Village
27. Plasmodium falciparum: The human agglutinating antibody response to the infected red cell surface is predominantly variant specific
28. Naturally acquired cellular and humoral responses to the major merozoite surface antigen (Pf MSPI) of Plasmodium falciparum are associated with reduced malaria morbidity
29. Protection, pathogenesis and phenotypic plasticity in Plasmodium falciparum malaria
30. An estimation of the number of malaria sporozoites ejected by a feeding mosquito
31. Analysis of the human antibody response to thrombospondin‐related anonymous protein of Plasmodium falciparum
32. A prospective study of the association between the human humoral response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections